Has anyone had trouble shearing formaldehyde crosslinked chromatin to small enough fragments to go into Illumina library prep? Our protocol calls for shearing to 200-300 bp fragments after crosslinking but it seems that we can't breakup the chromatin to anything less the ~800 bp by Bioanalyzer. We have tried traditional sonicator and Covaris. What are we doing wrong?
Announcement
Collapse
No announcement yet.
X
-
Hi,
I wonder which protocol you used to shear chromatin using Covaris? I have attached our two updated protocols. One is for using SDS based buffers, and one is for using non-ionic detergent based buffers. Please prepare your samples according to one of the protocols, and let me know how it works for you.
Thank you
Hamid
-
Hi,
The new SDS-based buffer protocol works just as well now, so you are welcome to try either protocol. My suggestion would be to use a sample volume of 500ul in the TC12 tubes.
What is the cell type, and cell number you are using in this experiment?
Thank you
Hamid
Comment
-
To me it sounds like you've overcrosslinked your chromatin. What is your crosslink strategy?
Also, I know with the bioruptor the tube choice makes a difference. Some tubes barely let any of the sonic energy through the tube wall. The TPX tubes from diagenode so far are the best. Since the TPX plastic is used in high sound frequency applications so it makes sense that it is the best.
Comment
-
hmmm. Interesting. We crosslink (thymocytes) at 1x10^6 cell/mL in 1% formaldehyde for 10 min in a 37 degree air incubator with rotation. Then quench with 0.125M glycine for 10 min on ice.
Your conditions seem mild enough. But I can't help but think they are somehow overcrosslinked. Have your conditions worked in the past and give you a more reasonable 300bp avg frag size?
Comment
Latest Articles
Collapse
-
by seqadmin
At the intersection of cytogenetics and genomics lies the exciting field of cytogenomics. It focuses on studying chromosomes at a molecular scale, involving techniques that analyze either the whole genome or particular DNA sequences to examine variations in structure and behavior at the chromosomal or subchromosomal level. By integrating cytogenetic techniques with genomic analysis, researchers can effectively investigate chromosomal abnormalities related to diseases, particularly...-
Channel: Articles
09-26-2023, 06:26 AM -
-
by seqadmin
Cancer research has been transformed through numerous molecular techniques, with RNA sequencing (RNA-seq) playing a crucial role in understanding the complexity of the disease. Maša Ivin, Ph.D., Scientific Writer at Lexogen, and Yvonne Goepel Ph.D., Product Manager at Lexogen, remarked that “The high-throughput nature of RNA-seq allows for rapid profiling and deep exploration of the transcriptome.” They emphasized its indispensable role in cancer research, aiding in biomarker...-
Channel: Articles
09-07-2023, 11:15 PM -
-
by seqadmin
Ribonucleic acid (RNA) represents a range of diverse molecules that play a crucial role in many cellular processes. From serving as a protein template to regulating genes, the complex processes involving RNA make it a focal point of study for many scientists. This article will spotlight various methods scientists have developed to investigate different RNA subtypes and the broader transcriptome.
Whole Transcriptome RNA-seq
Whole transcriptome sequencing...-
Channel: Articles
08-31-2023, 11:07 AM -
ad_right_rmr
Collapse
News
Collapse
Topics | Statistics | Last Post | ||
---|---|---|---|---|
Started by seqadmin, Yesterday, 06:57 AM
|
0 responses
9 views
0 likes
|
Last Post
by seqadmin
Yesterday, 06:57 AM
|
||
Started by seqadmin, 09-26-2023, 07:53 AM
|
0 responses
8 views
0 likes
|
Last Post
by seqadmin
09-26-2023, 07:53 AM
|
||
Multiplexed Biomarker Detection with Nanopore Technology: A Leap in Precision Diagnostics
by seqadmin
Started by seqadmin, 09-25-2023, 07:42 AM
|
0 responses
14 views
0 likes
|
Last Post
by seqadmin
09-25-2023, 07:42 AM
|
||
Started by seqadmin, 09-22-2023, 09:05 AM
|
0 responses
44 views
0 likes
|
Last Post
by seqadmin
09-22-2023, 09:05 AM
|
Comment